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Abstract Essential plant oils (or their active principles) are
safe to use and a potentially attractive alternative to current
antiparasitic drugs. In the present study, we tested the effects
of carvacrol on the isolated tissues of Ascaris suum and inves-
tigated potential interactions with other antiparasitic drugs.
We used somatic muscle flaps for contraction assays, as well
as for electrophysiological investigations. Carvacrol 300 μM
highly significantly inhibited contractions caused by 1, 3, 10,
30, and 100 μM of ACh (p=0.0023, p=0.0002, p=0.0002,
p<0.0001, and p<0.0001). The control EC50 for acetylcholine
was 8.87 μM (log EC50=0.95±0.26), while Rmax was
2.53±0.24 g. The EC50 of acetylcholine in the presence of
300 μM of carvacrol was 27.71 μM (log EC50=1.44±0.28)
and the Rmax decreased to 1.63±0.32 g. Furthermore, carvacrol
highly significant potentiates inhibitory effect of GABA and
piperazine on the contractions induced by ACh. However,
carvacrol (100 and 300 μM), did not produce any changes in
the membrane potential or conductance of the A. suum muscle
cell. While, 300 μM of carvacrol showed a significant
inhibitory effect on ACh-induced depolarization response.
The mean control depolarization was 13.58±0.66 mV and
decreased in presence of carvacrol to 4.50±1.02 mV
(p<0.0001). Mean control Δg was 0.168±0.017 μS, while in
the presence of 300 μM of carvacrol, Δg significantly
decreased to 0.060±0.018 ΔS (p=0.0017). The inhibitory
effect on contractions may be the explanation of the
antinematodal potential of carvacrol. Moreover, inhibition of
depolarizations caused by ACh and reduction of conductance
changes directly points to an interaction with the nAChR in
A. suum.
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Introduction
Infections of humans and animals with parasitic nematodes
are a significant health problem worldwide. Nematodes or
roundworms are the most diverse of all animals. Over 28,
000 nematode species have been described of which over
16,000 are parasitic (Hugot et al. 2001). There are many
parasitic forms of nematodes, which cause enormous eco-
nomic damage or physical suffering of animals. Humans
themselves are host to about 50 different roundworm spe-
cies, and they are the causative agents in 6 of the 13 core
neglected tropical diseases of humans, for example ascari-
asis, trichuriasis, hookworm disease, lymphatic filariasis,
onchocerciasis, and dracunculiasis (Payne and Fitchett
2010). These human diseases, caused by parasitic nema-
todes, affect more than 3 billion people (Anthony et al.
2007; Brooker 2010). Animal parasitic nematodes are also
a very significant burden on animal welfare and agricultur-
al livestock productivity globally and cause severe eco-
nomic losses (Paterson and Barber 2007). Some of the
most commonly used antinematodal drugs in human and
veterinary medicine are cholinergic agonists, which in-
clude imidazothiazole (levamisole) tetrahydropyrimidines
(pyrantel, morantel, and oxantel), quaternary/tertiary
amines (bephenium and tribendimidine), pyridines
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(methyridine), and the amino-acetonitrile derivatives
(AADs). The second group of antinematodal drugs is the
avermectins, agonists of GABA and glutamate-gated chlo-
ride channels in nematodes. Finally, the benzimidazoles
have an important place in antinematodal therapy as
broad-spectrum anthelmintic compounds that inhibit nem-
atode microtubule formation through b-tubulin binding
(Martin et al. 2014; Lacey 1990).
Current antiparasitic pharmacotherapy is faced with
several important issues. Reports relating to the resistance
of different parasitic nematodes to antiparasitic drugs are
becoming common, while the problem that increasing
doses of drugs carries a pronounced toxicity. Particularly
important for veterinary medicine is the fact that most of
antiparasitic drugs require a long withdrawal period after
administration in food production animals, which is an
important problem, both for veterinarians and farmers.
We have listed only the most important reasons that led
scientists to look towards plant-based alternatives instead
of conventional chemical antiparasitic drugs.
Plants produce essential oils as organic products of second-
ary metabolism. Essential oils (or their active principles) are
safe to use and a potentially attractive alternative to current
antiparasitic drugs. It is well documented that plant essential
oils demonstrate insecticidal and nematocidal activities
against a number of arthropod and worm species (Ellis and
Baxendale 1997; Enan 2005; Camurça-Vasconcelos et al.
2007; Barros et al. 2009). There is historical evidence that in
the beginning of twentieth century, thymol, the principal com-
ponent of thyme (Thymus vulgaris L.), was used for the treat-
ment of ascarids and hookworms in humans (Kaplan et al.
2014). Today, more and more attention is given to plant-
based functional food/feed against endoparasitic infections,
which could replace or potentiate the effects of classical an-
thelmintic therapy (Kaplan et al. 2014). This special food/feed
can contain essential plant oils or their active principles, thus
allow the using of functional food/feed against parasitic nem-
atode infection.
We are particularly interested in carvacrol, the active con-
stituent of thyme and oregano essential oils. Hierro et al.
(2004) have published that carvacrol is able to act in vitro on
L3 larvae of Anisakis simplex at a concentration of
12.50 μg/ml. Similar results have been published by Abdel-
Rahman et al. (2013), but this time as a nematocidal effect of
carvacrol on the model nematode Caenorhabditis elegans.
In the present study, we tested the effects of different con-
centrations of carvacrol on the isolated tissues of the large pig
nematode Ascaris suum. We used somatic muscle flaps for
contraction assays, as well as for electrophysiological investi-
gations. The aim of our study was to determine the nature of
the effects of carvacrol in the neuromuscular system of para-
sitic nematodes, as well as to evaluate potential interactions
with other antiparasitic drugs.
Materials and methods
A. suum
For the contraction assay, adult female A. suumwere collected
weekly from the slaughterhouse at Vrčin, Belgrade, Serbia.
For electrophysiological investigations, adult A. suum were
collected weekly from the JBS packing plant at
Marshalltown, IA, USA. Worms were maintained in Locke’s
solution, composition (mM): NaCl 155, KCl 5, CaCl2 2,
NaHCO3 1.5 and glucose 5, at a temperature of 32 °C. The
Locke’s solution was changed twice daily, and each batch of
worms was used within 4 days of collection.
Muscle flap for contraction
Ascaris muscle flaps for contractions were prepared by dis-
secting the anterior part of the worm, 2–3 cm caudal to the
head. After dissection, the lateral line was removed from the
edge of the flaps. While, each flap (always the same length of
1 cm) was monitored isometrically by attaching a force trans-
ducer in an experimental bath maintained at 37 °C, containing
20 ml Ascaris Perienteric Fluid Ringer/APF Ringer (mM):
NaCl, 23; Na-acetate, 110; KCl, 24; CaCl2, 6; MgCl2, 5; glu-
cose, 11; HEPES, 5; pH 7.6, and bubbled with room air. After
dissection, the preparations were allowed to equilibrate for
15 min under an initial tension of 0.5 g. Different concentra-
tions of acetylcholine were then added to the preparation (1, 3,
10, 30, and 100 μM), and the maximum contraction observed
before washing and subsequent application of the next con-
centration of acetylcholine. The responses for each concentra-
tion were expressed in grams (g), produced by each individual
flap preparation. The effects of carvacrol (100 and 300 μM),
GABA (1, 3, and 10μM), and piperazine (300μM) on control
acetylcholine dose-response plots were determined.
Contractions were monitored on a PC computer, using a
BioSmart interface, and eLAB software (ElUnit, Belgrade).
The system allows real time recording, displaying, and anal-
ysis of experimental data. Sigmoid dose-response curves for
each individual flap preparation at each concentration of an-
tagonist were described by the Hill equation.
Muscle flap for current-clamp recording
Ascaris muscle flaps for current-clamp recording were pre-
pared by dissecting the anterior part of the worm, 2–3 cm
caudal to the head. The flap was pinned, cuticle-side down,
onto a Sylgard™-lined chamber, where the intestine was re-
moved. The preparation was microperfused continuously with
APF. Application of the perfusate was via a fine microtube
placed with a micromanipulator (approximately 500 μm) over
the muscle cell bag. The rate of perfusion was 3.0 ml/min, and
this allowed rapid change of the solution in the isolated tissue
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bath. The temperature in the chamber was maintained at 32–
33 °C. A two-microelectrode current-clamp technique was
used for measuring the membrane potential and input conduc-
tance changes of the Ascaris muscle cell bags. Micropipettes
made from borosilicate glass o.d 1.55 mm, i.d. 0.86 mm,
(Clarke Electromedical, Reading, UK) with resistances in
the range of 20–30 MΩ when filled with 3 M potassium ace-
tate were used for recording. Two microelectrodes were care-
fully inserted into a single muscle cell bag with minimum
damage. An Axoclamp 2A amplifier, 1320A Digidata
Interface, pClamp 9.0 software (all from Axon Instruments,
Union City, CA, USA) and PC desktop computer were used to
display, record and analyze the membrane potential and
injected current. One micropipette was used for recording of
membrane potential, while the second was used for injection
of current pulses (hyperpolarizing, 40 nA; 500 ms filtered at
0.3 kHz). Our somatic muscle preparations had resting mem-
brane potentials greater than −25 mV and the resting input
conductances less than 4 μS. Acetylcholine was added to the
bag region of the cell via the microcatheter in the perfusate for
20 s, while carvacrol (100 and 300 μM) was added to the
preparation in the perfusate for at least 5 min before the appli-
cation of acetylcholine.
Drugs
Acetylcholine, carvacrol and GABA were obtained from
Sigma-Aldrich Co (St Louis, MO, USA), while piperazine
was obtained from Fluka (Sweden). Acetylcholine, GABA,
and piperazine were dissolved in the APF-Ringer, while car-
vacrol was dissolved in the ethanol, with a final concentration
of ethanol in the APF-Ringer of 0.1 % v/v. When tested, 0.1 %
of ethanol in APF-Ringer did not alter the resting activity of
preparations and did not alter the drug responses.
Analysis
In the contraction studies, sigmoid concentration dose-
responses were described by the equation as follows: % re-
sponse=1/1+[EC50/Xa]
nH, where EC50 is the concentration of
agonist (Xa) producing 50 % of the maximum response and
nH is the Hill coefficient (slope). Prism 5.0 (GraphPad
Software, San Diego, CA.) was used to estimate the constants
EC50 and nH, by non-linear regression for each preparation.
We determined mean contraction responses to each concen-
tration of acetylcholine (control dose-response: CR[Ach]);
mean responses to each of the concentrations of acetylcholine
in the presence of carvacrol, GABA, and piperazine. Paired t
tests were used to test differences between control contrac-
tions that were followed by test contractions on the samemus-
cle-flap.
In electrophysiological studies, using one-way ANOVA
test, we analyzed the differences in depolarization and change
in conductivity of the A. suum muscle cells, while differences
were considered significant at p<0.05. Depolarization was
induced by acetylcholine (10 μM) and observed before and
after the addition of carvacrol (100 and 300 μM). Statistical
analysis was done using Graphpad Prism software, while all
values are expressed as mean±S.E.
Results
Contractions
Figure 1a shows a representative recording of the Ascaris
muscle flap contractions, induced by increasing concentra-
tions of acetylcholine. When carvacrol was added at concen-
trations of 100 and 300 μM for 5 min, there was no change of
basal tone, but acetylcholine-induced contractions were re-
duced. Carvacrol 100 μM produced significant inhibition of
contractions induced by 1, 3, and 100 μMof ACh (p=0.0248,
p=0.0076, and p=0.0092) (Table 1). Figure 1b shows the
concentration-response plot of acetylcholine (mean±S.E.
bars), with and without carvacrol in the experimental bath.
The control mean effective concentration (EC50) for acetyl-
choline was 8.87 μM (log EC50=0.95±0.26), while maximal
effect (Rmax) was 2.53±0.24 g. Carvacrol (100 μM) did not
change the EC50 for acetylcholine, EC50=7.66 μM (log
EC50=0.88±0.24), but carvacrol did reduce the value of
Rmax to 2.20±0.21 g.
A higher concentration of carvacrol exhibited a more pro-
nounced inhibitory effect. Carvacrol (300 μM) highly signif-
icantly inhibited contractions caused by 1, 3, 10, 30, and
100 μM of ACh (p=0.0023, p=0.0002, p=0.0002,
p<0.0001, and p<0.0001) (Table 1). The EC50 of acetylcho-
line in the presence of 300 μM of carvacrol was 27.71 μM
(log EC50=1.44±0.28), and the Rmax decreased to 1.63±
0.32 g. Washing the preparations partially reversed the inhibi-
tion, with acetylcholine, EC50 after wash=14.69 μM (log
EC50=1.16±0.19) and Rmax=2.61±0.27 g.
Based on previous studies on the potential action of mono-
terpene compounds of essential oils on the GABA-receptor
(Tong and Coats 2012; Tong et al. 2013), we examined the
interaction of carvacrol with GABA. Figure 2a shows a rep-
resentative recording of the A. suum muscle contractions,
caused by increasing concentrations of acetylcholine and the
inhibitory effect of GABA. When GABA was applied at a
concentration of 1 μM, it did not cause changes in the basal
tone of the preparation, but reduced the contractions induced
by acetylcholine. Furthermore, the combination of 1 μM
GABA and 100 μM carvacrol, more intensely inhibited con-
tractions induced by acetylcholine, while 10 μM GABA and
100 μM carvacrol completely blocked contractions. It is inter-
esting that the recovery of contractions after the effect of the
GABA+carvacrol combination, was only partial (Fig. 2b,
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final set of contractions in presented recording). On the other
hand, combination of GABA 3 μM and carvacrol 300 μM
produced almost complete blockage of contractions (record-
ing not shown); therefore, there is no possibility of the mea-
suring contractile effects and changes. In accordance with the-
se preliminary results, we decided to test the effect and the
interaction, between GABA 3 μM and carvacrol 100 μM on
the contractions induced by increasing concentrations of ace-
tylcholine (Fig. 3a). The application of GABA did not change
the basal tone of the A. suum muscle strip, but significantly
inhibited the contractions induced by acetylcholine. Control
EC50 of acetylcholine in this series of investigation was
7.47 μM (log EC50=0.87±0.20), with Rmax=1.91±0.37 g.
Addition of 3 μM GABA had significant inhibitory effect on
contractions induced by 1, 3, 10, 30, and 100 μM of ACh (p=
0.0192, p=0.0032, p=0.0014, p=0.0015, and p=0.0098)
(Table 2). The value of EC50 of acetylcholine increased to
17.87 μM (log EC50=1.25±0.06), while Rmax decreased to
1.34±0.37 g. Further, intensive inhibition of contractions
was observed after administration of a combination of
GABA and carvacrol. The inhibitory effect of a combination
of GABA+carvacrol on contractions caused by 1, 3, 10, 30,
and 100 μM of ACh was highly significant (p=0.0014, p=
0.0009, p=0.0004, p<0.0001, p=0.0014) (Table 2). The EC50
was 25.84 μM (log EC50=1.42±0.11), whereas maximum
response 0.95±0.14 g (Fig. 3b). Washing of preparations part-
ly reversed contractions towards the control level (EC50=
13.89 μM, Rmax=1.84±0.31). The combination of GABA
and carvacrol exhibited a significantly greater inhibitory effect
on the contractions induced by acetylcholine, compared with
the effect of GABA itself (Table 2). Furthermore, we would
like to point out another interesting finding. In some experi-
ments, we did not wash the preparation with APF after adding
GABA+carvacrol, but once again incubated with 3 μM
GABA. Recorded contractions were slightly higher than con-
tractions in the first incubation with GABA, but after washing,
contractions were even higher than the control contractions in
the beginning of recording (Fig. 2b, last set of contractions).
Piperazine is an anthelminthic especially useful in the treat-
ment of partial intestinal obstruction caused by Ascaris. It has
been reported that piperazine mimics the action of GABA,
brings about hyperpolarization of Ascaris somatic muscle
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Fig. 1 a Isometric contraction of Ascaris suummuscle strip produced by
increasing concentrations of acetylcholine and inhibition of contractions
induced by carvacrol. Short bar indicates the application of acetycholine
(1, 3, 10, 30, and 100 μM), a full line the presence of carvacrol 100 μM,
and a dashed line the presence of carvacrol 300 μM. b The concentration-
response plot for acetylcholine showing mean±S.E. bars. Control (n=8);
in the presence of 100 μM carvacrol (n=8); and in the presence of
300 μM carvacrol (n=8); after washing (n=8, dashed line)
Table 1 Mean values of contractions (±S.E., g) of Ascaris suummuscle flaps caused by increasing concentrations of acetylcholine and the inhibitory
effect of carvacrol (100 and 300 μM) on these contractions
n=8 1 μM ACh 3 μM ACh 10 μM ACh 30 μM ACh 100 μM ACh
Control 0.54±0.08 1.11±0.15 1.40±0.17 2.09±0.25 2.35±0.21
Carvacrol 100 μM 0.26±0.04* 0.81±0.11** 1.16±0.16 1.84±0.21 2.03±0.24**
Carvacrol 300 μM 0.10±0.01** 0.26±0.07*** 0.35±0.10*** 0.96±0.17*** 1.26±0.19***
Wash 0.17±0.01 0.62±0.13 0.99±0.13 1.84±0.21 2.26±0.23
*p=0.0248
**p=0.0023
**p=0.0076
***p=0.0002
***p=0.0002 ***p<0.0001 **p=0.0092
***p<0.0001
*Statistically significant difference compared to control
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cells, that this is associated with relaxation and flaccid paral-
ysis (Martin 1982). We examined the antagonistic effect of
piperazine on contractions induced by acetylcholine, as well
as the potential interaction between piperazine and carvacrol.
At the beginning, we tested the effect of a combination of
piperazine 300 μM+carvacrol 300 μM, but it completely
blocked the contractile effects of acetylcholine. Therefore, in
order to measure the intensity of inhibition of contraction, we
tested a combination of piperazine 300 μM+carvacrol
100 μM. Figure 4a shows a representative recording of the
Ascaris muscle flap contractions induced by increasing con-
centrations of acetylcholine, as well the effects of piperazine
300 μM and piperazine 300 μM+carvacrol 100 μM.
Piperazine had significant inhibitory effect on contractions
induced by 1, 3, and 30 μM of ACh (p=0.0195, p=0.0248,
and p=0.0015) (Table 3). Control EC50 value of acetylcholine
in this series of investigations was 11.78 μM (log EC50=1.07
±0.22), while the maximal effect (Rmax) was 2.85±0.65 g (n=
6). In the presence of 300 μM piperazine, comparable values
were EC50=12.52μM (log EC50=1.10±0.16) and Rmax=2.08
±0.32 g. The inhibitory effect of the combination of these two
substances on the contractions induced by acetylcholine (1, 3,
10, 30, and 100 μM) was even more convincing and highly
significant (p=0.0072, p=0.0006, p=0.0006, p<0.0001, p=
0.0015) (Table 3). EC50 was 21.48 μM (log EC50=1.33±
0.17) and the maximal effect only 0.95±0.17 g. Similarly as
in the experiments with GABA, the combination of piperazine
and carvacrol produced a significantly greater inhibitory effect
on the contractions caused by acetylcholine, compared with
the effect of piperazine itself (Table 3). Recovery after wash-
ing was partial, EC50 value of 16.45 μM and a maximum
contractile effect was 2.35±0.25 g.
In these investigations, we noticed another interesting find-
ing. After administration of a combination of carvacrol + pi-
perazine, there was enhancement of spontaneous contractile
activity of preparations (labeled a, b, c in Fig. 4a). The in-
crease in spontaneous contractility was reversible on washing.
Electrophysiological studies
In order to analyze the mechanism of antinematodal action of
carvacrol in more detail, we tested its effect on the depolari-
zation of A. suum muscle cell induced by acetylcholine.
Carvacrol, by itself (100 and 300 μM), did not produce any
changes in the membrane potential or conductance of the
A. suum muscle cell (Figs. 5a and 6a). However, carvacrol
had a rapid (within 5 min) reversible inhibitory effect on
acetylcholine-induced depolarizations under current-clamp.
The lowest concentration of carvacrol tested, 100 μM, caused
no significant (one-way ANOVA), reversible reduction of
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Fig. 2 a Isometric contraction of
Ascaris suum muscle strip
produced by application of
increasing concentrations of
acetylcholine, and inhibition of
contractions induced by GABA
and carvacol. Short bar indicates
the application of acetylcholine
(1, 3, 10, 30, and 100 μM), a full
line the presence of GABA 1 or
10 μM, and a dashed line the
presence of 300 μM carvacrol. b
Isometric contraction of Ascaris
suum muscle strip, produced by
increasing concentrations of
acetylcholine, and inhibition of
contractions induced by GABA
and carvacrol. Short bar indicates
the application of acetylcholine
(1, 3, 10, 30, and 100 μM), a full
line the presence of GABA
(3 μM), and a dashed line the
presence of carvacrol (100 μM)
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depolarization induced by acetylcholine. Figure 5a shows a
representative recording of the inhibition of depolarization
produced by a short application of 100 μM carvacrol. The
mean control value was 10.56±1.72 mV that decreased in
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Fig. 3 a Isometric contraction of Ascaris suummuscle strip produced by
application of increasing concentrations of acetylcholine, and inhibition
of contractions induced by GABA and carvacrol. Short bar indicates the
application of acetylcholine (1, 3, 10, 30, and 100 μM), a full line the
presence of 3 μM GABA, and a dashed line the presence of 100 μM
carvacrol. b The concentration-response plot of acetylcholine showing
mean±S.E. bars. Control (n=6); in the presence of 3 μM GABA (n=
6); in the presence of 3 μM GABA and 100 μM carvacrol (n=6); after
washing (n=6, dashed line)
Table 2 Mean values of contractions (±S.E., g) of Ascaris suummuscle flaps caused by increasing concentrations of acetylcholine and the inhibitory
effect of GABA (3 μM) and carvacrol (100 μM) on these contractions
n=6 1 μM ACh 3 μM ACh 10 μM ACh 30 μM ACh 100 μM ACh
Control 0.24±0.04 0.73±0.11 0.99±0.11 1.45±0.08 1.70±0.08
GABA 3 μM 0.05±0.02* 0.18±0.01** 0.32±0.04** 1.08±0.11** 1.32±0.10**
GABA 3 μM + Carvacrol 100 μM 0** 0.06±0.02***,++ 0.12±0.01***,++ 0.56±0.10***,+++ 0.90±0.17**,+
Wash 0.27±0.06 0.49±0.05 0.85±0.13 1.33±0.09 2.26±0.23
*p=0.0192
**p=0.0014
**p=0.0032
***p=0.0009
++p=0.0012
**p=0.0014
***p=0.0004
++p=0.0018
**p=0.0015
***p<0.0001
+++p=0.0002
**p=0.0098
**p=0.0014
+p=0.0146
*Statistically significant difference compared to control
+ Statistically significant difference compared to GABA
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Fig. 4 a Isometric contraction of Ascaris suummuscle strip, produced by
increasing concentrations of acetylcholine, and inhibition of contractions
induced by piperazine and carvacrol. Short bar indicates the application of
acetylcholine (1, 3, 10, 30, and 100 μM), a full line the presence of
300 μM piperazine, and a dashed line the presence of 100 μM
carvacrol. b The concentration-response plot of acetylcholine showing
mean±S.E. bars. Control (n=6); in the presence of 300 μM piperazin
(n=6); in the presence of 300 μM piperazine and 100 μM carvacrol
(n=6); after washing (n=6, dashed line)
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the presence of carvacrol to 6.75±1.00 mV. Washing returned
the depolarization to the control level, 10.35±2.11 mV (n=4),
respectively (Fig. 5b). Although, there was no significant de-
crease in acetylcholine-induced depolarization, 100 μM of
carvacrol has significantly reduced the value of conductance
change (Δg). Control value of Δg was 0.190±0.021 μS,
while in the presence of carvacrol, Δg decreased to 0.107±
0.021 μS (p=0.0207, n=4). After washing, Δg returned to
0.175±0.02 μS, which was close to the control value (Fig. 5c).
Figure 6a shows a representative recording of
acetylcholine-induced depolarizations and inhibition of
depolarizations produced by a short application of 300 μM
carvacrol. The mean control depolarization was 13.58±
0.66 mV, while this value was decreased in presence of car-
vacrol to 4.50±1.02 mV. After washing, the average depolar-
ization induced by acetylcholine approached the control value
11.32±0.84 mV (n=5), respectively. The bar chart in Fig. 6b
summarizes results from five separate preparations and indi-
cates that carvacrol produced a significant inhibition of depo-
larization (p<0.0001, one-way ANOVA), which was revers-
ible after washing (p<0.0001, one-way ANOVA). The bar
chart in Fig. 6c summarizes results of carvacrol (300 μM)
Table 3 Mean values of contractions (±S.E., g) of Ascaris suummuscle flaps caused by increasing concentrations of acetylcholine and the inhibitory
effect of piperazine (300 μM) and carvacrol (100 μM) on these contractions.
n=6 1 μM ACh 3 μM ACh 10 μM ACh 30 μM ACh 100 μM ACh
Control 0.25±0.04 0.78±0.09 1.23±0.14 2.21±0.08 2.54±0.34
Piperazine 300 μM 0.13±0.01* 0.46±0.07* 0.89±0.10 1.08±0.11** 1.98±0.32
Piperazine 300 μM + Carvacrol 100 μM 0.07±0.01**,++ 0.12±0.02***,++ 0.17±0.02***,+++ 0.56±0.10***,+++ 0.95±0.25**,+
Wash 0.11±0.01 0.31±0.06 0.65±0.29 1.33±0.09 2.33±0.52
*p=0.0195
**p=0.0072
++p=0.0012
*p=0.0248
***p=0.0006
++p=0.0059
***p=0.0006
+++p=0.0008
**p=0.0015
***p<0.0001
+++p=0.0002
**p=0.0015
+p=0.017
*Statistically significant difference compared to control
+ Statistically significant difference compared to GABA
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Fig. 5 a Representative trace
shows depolarizations to three
control applications of 10 μM
acetylcholine (15 s), short bars.
The applications of acetylcholine
were repeated in the presence
100 μM carvacrol (after 5 min
exposure of the preparations to
carvacrole) and after washing. b
Bar chart summarizing the results
shows a nonsignificant reduction
in amplitude of acetylcholine
depolarizations in the presence of
carvacrol 100 μM (n=4, p=
0.2483). c Bar chart summarizing
the results shows a significant
reduction in conductance changes
(Δg) caused by acetylcholine in
the presence of carvacrol 100 μM
(n=4, p=0.0207)
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on the conductance changes caused by acetylcholine. Mean
control Δg was 0.168±0.017 μS, while in the presence of
300 μM carvacrol; Δg decreased to 0.060±0.018 μS. After
washing the conductance changes produced by acetylcholine
are almost recovered to the control level, 0.148±0.012 μS.
The reduction in conductance changes, caused by acetylcho-
line in the presence of 300 μM carvacrol, was significant
compared to the control, as well as to the value after washing
(p=0.0017, one-way ANOVA).
Discussion
Carvacrol is present in many plant essential oils, such as
thyme oil and oregano oil. It is a phenolic monoterpenoid,
which is a class of secondary metabolites found in plant
essential oils. In this study, we were interested to investigate
the mechanism of antinematodal action of carvacrol. Themain
reason for this was that several researchers published studies
indicating that carvacrol has a high antiparasitic potency. Lei
et al. (2010) showed that carvacrol and thymol at concentra-
tions of 330 μM caused an A. suum mortality rate of 80 %
(in vitro test during 24 h). When carvacrol was applied
in vitro, at concentrations of 6.25 and 12.50 mg/ml, it caused
lethal effects in 90 and 100 % of L3 A. simplex larvae, after 1
and 24 h of exposition (Hierro et al. 2004). Abdel-Rahman
et al. (2013) evaluated the nematocidal activity of 34 terpe-
noids, commonly found as constituents of plant essential oils,
against the free living nematode C. elegans. Based on their
results, the most efficient nematocidal compound was carva-
crol, with LC50 of 3 μg/ml.
In our research, carvacrol clearly exhibited an inhibitory
effect on the contractions of A. suum induced by acetylcho-
line. This inhibitory effect on contractions may be the expla-
nation of the antinematodal potential of carvacrol. Carvacrol
(100 and 300 μM), by itself did not change the basal tone of
muscle flaps, but exhibited the characteristics of a competitive
and non-competitive antagonist of acetylcholine-induced con-
tractions. At the lower tested concentration, carvacrol reduced
the Rmax by 13 %, while the higher dose shifted the effective
curve to the right, increasing the value for acetylcholine EC50
three times, from 8.87 to 27.70 μM, and gave a dose-ratio of
3.12. Furthermore, the maximal contractile effect was reduced
bymore than 30% (from 2.52 to 1.63 g). Previously, there has
been a limited amount of published data concerning the mech-
anism of antinematodal action of carvacrol, showing a possi-
ble interaction with a tyramine receptor (Lei et al. 2010).
Tyramine inhibits head movements and forward locomotion
through the activation of a tyramine-gated chloride channel in
C. elegans (Pirri et al. 2009). The inhibitory effect of carvacrol
in our studies developed rapidly, after 5 min exposure of the
muscle flap, which is much faster than the inhibitory effect
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Fig. 6 a Representative trace
shows depolarizations to three
control applications of 10 μM
acetylcholine (15 s), short bars.
The applications of acetylcholine
were repeated in the presence
300 μM carvacrol (after 5 min
exposure of the preparations to
carvacrole) and after washing. b
Bar chart summarizing the results
shows a significant reduction in
amplitude of acetylcholine
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carvacrol 300 μM (n=5,
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caused by biogenic amines via their receptors. It is important
that tyramine did not alter locomotory waves when injected
into A. suum. The lack of any effect of tyramine may reflect
the localization of the tyramine-gated channel in the head, but
not in the body wall muscle of A. suum (Komuniecki et al.
2012). The real functional importance and localization of
tyramine-dependent chloride channels in A. suum remains
unclear.
Tong and Coats (2012) and Tong et al. (2013) have shown
that carvacrol binds to the GABA and tyramine receptors, and
thereby can cause an inhibitory effect on the insect nervous
system. However, the same authors published data that carva-
crol is able to bind nAChRs in the house fly head at a binding
site distinct from nicotine and inhibited the binding of [14C]-
nicotine to the house fly nAChRs non-competitively. The di-
versity of interactions with different types of receptors in other
invertebrates (insects), and the inhibition of contraction in
A. suum that we have observed in our experiments, motivated
us to investigate the interaction between carvacrol and the
major inhibitory neurotransmitter in nematodes—GABA. It
has long been known that nematodes have inhibitory
GABA-gated chloride channels at the neuromuscular junction
(Holden-Dye et al. 1989; Richmond and Jorgensen 1999).
These channels are involved in the nematodes sinusoidal
movement, with muscles on either side of the body alternately
contracting and relaxing. The GABA receptors mediate the
relaxation. Martin (1982) demonstrated that, in the bag region
of the A. suummuscle cells exist extra-synaptic GABA recep-
tors whose activation gives rise to an increase in Cl- conduc-
tance. We found that 1 μM GABA is able to inhibit the con-
tractions induced by acetylcholine without altering the basal
tone of muscle flap, while the combination of GABA 10 μM
and carvacrol 100 μMcompletely blocked contractions. In the
next series of contraction studies, 3 μM GABA shifted the
acetylcholine EC50 value to the right, from 7.47 to
17.87 μM, producing a dose-ratio of 2.39 and reducing the
maximum contractile effect by≈30 %. GABA is the major
inhibitory transmitter in the neuromuscular system of nema-
todes, and its inhibitory effect on the contractions induced by
acetylcholine should be completely non-competitive.
However, our results show that one part of the GABA activity
is competitive, because concentration-response curves are
shifted to the right. One possible explanation for these specific
properties of GABA might be connected with its double ac-
tion. We hypothesize that the first part of action is a conse-
quence of binding to GABA-receptor in the synapses between
inhibitory interneurons and motoneurons (synaptic effect).
While the second part of action is a postsynaptic effect, in-
volving GABA-receptors on the bag region of muscle cells.
The first part can present as competitive inhibition, which
immediately activates antagonistic excitatory mechanism
(through excitatory interneurons) and second postsynaptic ac-
tion, causes non-competitive inhibition of contractions.
Increase of the acetylcholine contractile effect after washing
of GABA is something that we have already observed, after
washing of the neuropeptide AF2 in previous investigations
(Trailovic et al. 2005). This phenomenon certainly requires
analysis that is more detailed and future research, especially
since these have not been observed after washing a combina-
tion of GABA + carvacrol.
In the order to verify this hypothesis, we have examined the
interaction of piperazine and carvacrol in the inhibition of con-
tractions induced by acetylcholine. Piperazine behaved as a
classical non-competitive antagonist in this study. The value
of the control acetylcholine EC50 has not changed in the pres-
ence of piperazine 300 μM, but the maximum effect was re-
duced by 27 %. When 100 μM of carvacrol was added to the
experimental bath with piperazine (300 μM), the
concentration-response curve for acetylcholine was shifted to
the right, and the EC50 value increased from 11.78 to
21.48 μM, giving a dose-ratio of 1.82. This combination re-
duced the Rmax by 66.67 %, from 2.85 to 0.95 g, respectively.
Interestingly, a combination of piperazine + carvacrol increased
spontaneous contractile activity of A. suummuscle flaps, which
was reversible on washing. Carvacrol brings a competitive
component to this combination of two antagonists of acetyl-
choline effects. However, carvacrol reduced themaximum con-
tractile effect, which may point to a very specific mechanism of
action and probably multiple binding sites in the neuromuscu-
lar system of the nematodes. Possibly, this is the reason that
carvacrol (300 μM) in combination with piperazine completely
blocked the acetylcholine-induced contractions.
In our electrophysiological current clamp studies, we found
that carvacrol by itself was not able to cause hyperpolarization,
which would be observed if it was directly opening chloride
channels in the muscle cells, but the possibility of a presynaptic
interaction with interneurons or motoneurons remains.
Carvacrol inhibits depolarizations caused by acetylcholine and
reduces conductance changes that directly points to an interac-
tion with the nAChR in A. suum. This effect was observed at
both tested concentrations of carvacrol, 100 and 300 μM.
The results of the present study are encouraging for the
possibility for developing new anthelmintic compounds that
may overcome parasite resistance and potentiate the effect of
existing drugs. These compounds should have multiple sites
of antiparasitic action, which would prevent the development
of resistance. Carvacrol is a serious candidate for this type of
anthelmintic product and could be included in the content of
functional food/feed. Generally regarded as safe, carvacrol
can be used for the prevention of nematode infection, or for
potentiating the effects of anthelmintic drugs, both in human
and veterinary medicine.
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